(Q33939576)

English

Applying the 2005 Canadian Hypertension Education Program recommendations: 2. Assessing and reducing global atherosclerotic risk among hypertensive patients

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Applying the 2005 Canadian Hypertension Education Program recommendations: 2. Assessing and reducing global atherosclerotic risk among hypertensive patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

atherosclerosis

1 reference

based on heuristic

inferred from title

Brenda R. Hemmelgarn

1

object named as

Brenda R Hemmelgarn

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

author name string

Steven Grover

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Ross D Feldman

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Canadian Hypertension Education Program

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

language of work or name

0 references

publication date

1 September 2005

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Canadian Medical Association Journal

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

173

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

593-595

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part 1- blood pressure measurement, diagnosis and assessment of risk.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1197156

28 July 2018

Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1197156

28 July 2018

Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1197156

28 July 2018

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1197156

29 October 2018

Identifiers

10.1503/CMAJ.050185

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33939576&oldid=1646248262"